Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel in Netherton Syndrome
NCT00208026Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Sep 2005
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pimecrolimus in Netherton syndrome (NS), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Blood Pimecrolimus Levels at Day 520. Started Sep 2005; status: completed.
02
Drugs
pimecrolimus
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on NCT00208026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208026.